CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Also known as a vestibular schwannoma, a non-cancerous (benign) brain tumour.
Also known as vestibular schwannoma, an acoustic neuroma is a tumour that grows slowly from the covering on the vestibular nerve. This nerve runs from the inner ear to the brainstem and plays a role in maintaining your balance. The tumour is benign, which means it is not cancerous.
They are not strictly brain tumours as they grow from nerve sheath cells (schwann cells) and push against the hind brain (cerebellum) and brain stem only when they are large. A neuroma can still cause balance problems, hearing loss and facial pain and numbness, if the tumour is large enough to put pressure on your brain stem.
The most common symptoms of a vestibular schawnnoma include:
Vestibular schwannomas tend to affect adults. They are easily found on MRI scans, but because the symptoms of hearing loss and tinnitus can be caused by other conditions, such as Meniere's disease, scans and the diagnosis are sometimes delayed.
If your consultant suspects you have a vestibular schwannoma, they may perform one or all of the following:
Your consultant will then discuss the results of any tests with you.
Your consultant will discuss treatment options with you depending on the position and size of your neuroma, how quickly the tumour is growing, and your general health.
Among the main treatment options are:
Radiotherapy treatments have increased in popularity over the past 20 years. The term radiosurgery is generally considered to mean treatment after one session (fraction), but up to 5 fractions can be used in some centres and this is still regarded internationally as being radiosurgery. A single fraction is generally used to treat vestibular schwannomas. The dose of radiation given has reduced over the past 20 years, with a consequent reduction in side effects but without any noticeable reduction in the effectiveness.
Although the term ‘Gamma Knife’ implies a surgical cutting of tissue, no knives are involved, and the technique employs converging beams of radiation, delivering a high dose of radiation to the tumour, with a much lower dose to the surrounding tissue. The success of treatment is measured by growth arrest rather than tumour removal with the efficacy being at least 95% as shown by the latest published results.
There are different radiotherapy tools for delivering radiosurgery treatments, including Gamma Knife and TrueBeam. It is considered that these treatments are probably equivalent, but Gamma Knife has the longest track record and most of the published results.
A specialist service for children is offered by HCA UK at a number of locations. This includes;
This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.